Pediatric Acute Lymphoblastic Leukemia: Clinical Characteristics, Treatment Outcomes, and Prognostic Factors: 10 Years' Experience From a Low- and Middle-Income Country A retrospective cohort study ...

Denosumab Prevents Bone Loss and Microarchitectural Deterioration in Premenopausal Women With Breast Cancer Receiving Estradiol Suppression Therapy: A Randomized Controlled Trial Studying 767 children ...

Phase 1b–2 trial evaluates the potential of CAR T-cell therapy obe-cel in relapsed or refractory B-cell ALL patients. Chimeric antigen receptor (CAR) T-cell therapy has shown promise in inducing ...

The FDA has approved obecabtagene autoleucel for the treatment of adults with relapsed refractory B-cell precursor acute lymphoblastic leukemia. The approval followed a multicenter, open-label, single ...

This analysis sought to estimate future savings that could result from discontinuing tyrosine kinase inhibitor therapy among patients with chronic myeloid leukemia who experience a sustained deep ...

Acute myeloid leukemia (AML) is a type of leukemia, a cancer of the blood and bone marrow. AML specifically affects the myeloid cells, which are immature white blood cells. It is one of the most ...